SUN PHARMACEUTICAL INDUSTRIES
Back to All Ratios
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 20.88 | 19.89 | 19.51 | 5.07 | 3.72 |
What is the latest Profit After Tax (PAT) Margin ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 20.88 |
| Mar2024 | 19.89 |
| Mar2023 | 19.51 |
| Mar2022 | 5.07 |
| Mar2021 | 3.72 |
How is Profit After Tax (PAT) Margin of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 20.88 | 4.98 | |
| Mar2024 | 19.89 | 1.95 | |
| Mar2023 | 19.51 | 284.81 | |
| Mar2022 | 5.07 | 36.29 | |
| Mar2021 | 3.72 | - | |
Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,164.5 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
| MANKIND PHARMA | ₹92,658.1 Cr | 1.1% | -8.2% | -14.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% |
6.6% |
-2.1% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses